.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
UBS
Chubb
US Army
Cantor Fitzgerald
McKinsey
Queensland Health
Julphar
Farmers Insurance
Johnson and Johnson

Generated: June 23, 2017

DrugPatentWatch Database Preview

RIFAMPIN AND ISONIAZID Drug Profile

« Back to Dashboard

What is the patent landscape for Rifampin And Isoniazid, and what generic Rifampin And Isoniazid alternatives are available?

Rifampin And Isoniazid is a drug marketed by Hikma Intl Pharms and is included in one NDA.

The generic ingredient in RIFAMPIN AND ISONIAZID is isoniazid; rifampin. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the isoniazid; rifampin profile page.

Summary for Tradename: RIFAMPIN AND ISONIAZID

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list104,416
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RIFAMPIN AND ISONIAZID at DailyMed

Pharmacology for Tradename: RIFAMPIN AND ISONIAZID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms
RIFAMPIN AND ISONIAZID
isoniazid; rifampin
CAPSULE;ORAL065221-001Jul 29, 2005DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Baxter
Teva
Queensland Health
Julphar
Cerilliant
Citi
Express Scripts
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot